StockMarketWire.com - Biomarker company Oxford BioDynamics posted a first-half loss after revenue fell and costs rose.

Pre-tax losses for the six months through March amounted to £2.3m, compared to losses of £1.6m on-year.

Revenue slipped to £0.2m, back from £0.6m, while R&D and staff costs both increased.




Story provided by StockMarketWire.com